Patheon 1Q Revenues: $171.7 million (+9%) 1Q Loss: $2.6 million (loss of $11.5 million 1Q2006) Comments: Revenues from Rx manufacturing services grew 13% to $14.2 million, reflecting higher volumes at the Canadian, European and PR operations. Pharmaceutical development services (PDS) revenues increased 23% to $5 million, due to growth at the Toronto, Cincinnati and Swindon operations. Repositioning expenses — related to workforce reduction and the expansion of the company&#821...